Welcome to our dedicated page for Pluri SEC filings (Ticker: PLUR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Pluri Inc. SEC filings document the governance, capital-structure, listing-status, and material-event disclosures of a biotechnology company using a proprietary cell-based platform. Proxy materials cover annual shareholder meeting matters, director elections, auditor ratification, and board governance.
Pluri’s Form 8-K filings record events such as board composition changes, executive equity awards, Nasdaq Capital Market listing-standard notices and compliance updates, material agreements, shareholder voting matters, and capital-structure disclosures. These filings provide the formal record for corporate actions affecting the company’s common shares, governance framework, and public-company reporting obligations.
Pluri Inc. (PLUR) updated its at-the-market equity program, conducted through A.G.P./Alliance Global Partners as sales agent, to reduce the maximum aggregate amount of common shares that may be offered under its Sales Agreement. The overall program size is decreased from $10,000,000 to $290,000 as of August 26, 2026. From the start of the program to this date, Pluri has already sold $990,344 of common shares under the Sales Agreement. Under this updated prospectus supplement, Pluri may now offer and sell additional common shares with a maximum aggregate offering price of $290,000 from time to time through A.G.P. as sales agent or principal. The common shares trade on Nasdaq under the symbol PLUR, and the last reported sale price on August 26, 2026 was $1.48 per share.
Pluri Inc. (PLUR) reported that director Doron Shorrer received an equity grant of 31,569 shares of Common Stock on August 20, 2026, classified as a grant, award, or other acquisition at a stated price of $0.00 per share.
According to the footnote, these shares consist of common stock underlying restricted stock units (RSUs) granted by the Board of Directors on that date. The RSUs vest over three years: 50% vest on a quarterly basis during the first year after grant, 25% vest quarterly during the second year, and the remaining 25% vest quarterly during the third year. Following this grant, Shorrer directly holds 38,228 common shares and indirectly holds 6,969 common shares through Shorrer International Ltd.
Pluri Inc. (symbol: PLUR) is the issuer of record for a Form 4 filing submitted to the SEC.
Pluri Inc. reported that Ever After Foods Ltd. (EAF), its indirect majority-owned subsidiary, agreed to acquire all outstanding share capital of Fishway BV through an exchange of EAF ordinary shares. The deal is intended to support EAF’s European strategy via Fishway’s Belgian presence and research on cell lines and culture media for potential cultivated seafood applications.
Concurrently, EAF and certain Fishway security holders entered into a simple agreement for future equity under which these investors will provide an aggregate principal of $2.0 million to EAF. Pluri currently indirectly owns about 69% of EAF and expects its indirect interest to decrease to about 58% after completion, reflecting dilution from the share issuance and SAFE investment. Pluri is not a party to the transaction agreements. Closing is expected within 30 days of August 12, 2026, subject to customary corporate and closing conditions.
Pluri Inc. reports on ongoing discussions with the European Investment Bank regarding a finance agreement that provides for up to €50 million in funding, of which a first tranche of €20 million was drawn in June 2021 at 4% per annum and was due June 1, 2026.
The company states that since April 21, 2026 it has been in constructive talks with the EIB about potential alternatives, including a possible maturity extension. The EIB indicated discussions are advancing constructively, subject to internal approvals and legal review, but Pluri cautions there is no assurance of approvals, a definitive resolution, or continued forbearance from EIB remedies.
Pluri Inc. reports that on July 7, 2026 it received a Nasdaq notice that it is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires a minimum market value of listed securities of $35 million for continued listing on The Nasdaq Capital Market. Pluri also does not currently meet the alternative standards of stockholders’ equity of at least $2.5 million or net income of $500,000 from continuing operations in the most recent year or two of the last three years.
The company’s common shares continue trading on Nasdaq under the symbol PLUR, and Pluri has 180 calendar days, until January 4, 2027, to regain compliance. If its market value closes at or above $35 million for at least 10 consecutive business days during this period, Nasdaq will confirm compliance. If compliance is not regained, Pluri expects a delisting notice but could appeal to a Nasdaq Hearings Panel. Management is evaluating options to regain compliance, while cautioning that success is not assured.
Pluri Inc. director Doron Shorrer has filed an initial Form 3 reporting his beneficial ownership of the company’s common stock. The filing shows indirect ownership of 6,969 shares of Common Stock held "By Shorrer International Ltd." and direct ownership of 6,659 shares of Common Stock in his own name.
Pluri Inc. director and 10% owner Alexandre Weinstein reported routine equity compensation and a warrant expiration. He received 641 shares of Common Stock as a grant or award at no cost, bringing his directly held common shares to 6,925 following the transaction.
The filing notes he has been granted 10,769 restricted stock units (RSUs) under two equity compensation plans. As of the current date, 6,284 RSUs have vested, 641 RSUs are scheduled to vest within 60 days, and 3,844 RSUs remain unvested and subject to future vesting conditions.
Separately, 625,000 Common Warrants held indirectly through Chutzpah Holdings LP, each exercisable for one Common Share at an exercise price of $4.25 per share, expired on June 30, 2026 with no remaining position from that warrant grant.
Pluri Inc. major shareholder Alexandre Weinstein and his affiliated entities report updated ownership and warrant details in this amended Schedule 13D. As of June 30, 2026, the reporting group beneficially owns 4,352,641 Pluri common shares, calculated as approximately 38.01% of shares outstanding but contractually capped at 35% by a beneficial ownership blocker.
Chutzpah Holdings Ltd. holds 2,018,014 shares, including warrants for 84,599 shares. Chutzpah Holdings LP holds 1,875,000 shares, combining 1,250,000 common shares and warrants for 625,000 shares at $4.25 per share, subject to a 35% Beneficial Ownership Limitation. Plantae Bioscience Ltd. holds 452,702 shares, and Weinstein directly holds 6,925 shares including vested and near-term vesting RSUs. This amendment also notes the expiration of 625,000 earlier CHLP warrants on June 30, 2026 and summarizes key securities purchase and asset purchase agreements underpinning these positions.
Pluri Inc. entered into an Advance Subscription Agreement with Chutzpah Holdings LP, under which the investor paid an advance amount of $1,250,000 on June 16, 2026 for use as working capital and general corporate purposes. The amount is expected to be credited against securities the investor may purchase in a Board-approved financing to be consummated on or before August 14, 2026, subject to Nasdaq rules, corporate approvals and available authorized shares.
Following the 2026 annual meeting, director Eitan Ajchenbaum was not re-elected and left the Board, including his roles as Audit Committee chair and sole Investment Committee member. On June 19, 2026, the Board appointed company founder Doron Shorrer as a non-executive director, chairman of the Audit Committee, audit committee financial expert, and sole member of the Investment Committee. Shareholders also ratified Kesselman & Kesselman as Pluri’s independent registered public accounting firm for the fiscal year ending June 30, 2026.